Kezar Life Sciences, Inc.·4

Jun 27, 4:16 PM ET

Dinges Jason 4

4 · Kezar Life Sciences, Inc. · Filed Jun 27, 2019

Insider Transaction Report

Form 4
Period: 2019-06-25
Dinges Jason
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-06-25+8,8968,896 total
    Exercise: $7.63Exp: 2029-06-24Common Stock (8,896 underlying)
Footnotes (1)
  • [F1]One-hundred percent (100%) of the shares subject to the option shall vest on 6/25/2020, subject to Reporting Person continuing to provide service through such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION